BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 29136563)

  • 1. Generation of human iPSC line from a patient with laterality defects and associated congenital heart anomalies carrying a DAND5 missense alteration.
    Cristo F; Inácio JM; Rosas G; Carreira IM; Melo JB; de Almeida LP; Mendes P; Martins DS; Maio J; Anjos R; Belo JA
    Stem Cell Res; 2017 Dec; 25():152-156. PubMed ID: 29136563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and characterization of a human iPS cell line from a patient-related control to study disease mechanisms associated with DAND5 p.R152H alteration.
    Pars S; Cristo F; Inácio JM; Rosas G; Carreira IM; Melo JB; Mendes P; Martins DS; de Almeida LP; Maio J; Anjos R; Belo JA
    Stem Cell Res; 2018 May; 29():202-206. PubMed ID: 29730570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of EHMT1 mutant induced pluripotent stem cell (iPSC) line from a 11-year-old Kleefstra syndrome (KS) patient with autism and normal intellectual performance.
    Varga E; Nemes C; Táncos Z; Bock I; Berzsenyi S; Lévay G; Román V; Kobolák J; Dinnyés A
    Stem Cell Res; 2016 Nov; 17(3):531-533. PubMed ID: 27789404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a gene-corrected human induced pluripotent stem cell line derived from a patient with laterality defects and congenital heart anomalies with a c.455G > A alteration in DAND5.
    Inácio JM; Almeida M; Cristo F; Belo JA
    Stem Cell Res; 2020 Jan; 42():101677. PubMed ID: 31869685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and characterization of an induced pluripotent stem cell (iPSC) line from a patient with clozapine-resistant Schizophrenia.
    Marsoner F; Marcatili M; Karnavas T; Bottai D; D'Agostino A; Scarone S; Conti L
    Stem Cell Res; 2016 Nov; 17(3):661-664. PubMed ID: 27934603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of induced pluripotent stem cell (iPSC) line from an 8-year old female patient with ischemic Moyamoya disease.
    Cardano M; Marsoner F; Zasso J; Marcatili M; Karnavas T; Lanterna LA; Conti L
    Stem Cell Res; 2016 Nov; 17(3):619-622. PubMed ID: 27934593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of induced pluripotent stem cell (iPSC) line from 55-year old male patient with hemorrhagic Moyamoya disease.
    Cardano M; Marsoner F; Marcatili M; Karnavas T; Zasso J; Lanterna LA; Conti L
    Stem Cell Res; 2016 Nov; 17(3):623-626. PubMed ID: 27934594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of integration-free induced pluripotent stem cell lines derived from two patients with X-linked Alport syndrome (XLAS).
    Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
    Stem Cell Res; 2017 Dec; 25():291-295. PubMed ID: 29150092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of an induced pluripotent stem cell (iPSC) line from a patient with Clozapine-responder Schizophrenia.
    Marcatili M; Marsoner F; D'Agostino A; Karnavas T; Bottai D; Scarone S; Conti L
    Stem Cell Res; 2016 Nov; 17(3):630-633. PubMed ID: 27934596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of an iPSC line from a patient with GTP cyclohydrolase 1 (GCH1) deficiency: HDMC0061i-GCH1.
    Jung-Klawitter S; Ebersold J; Göhring G; Blau N; Opladen T
    Stem Cell Res; 2017 Apr; 20():38-41. PubMed ID: 28395739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of an induced pluripotent stem cell (iPSC) line from a patient with autosomal dominant retinitis pigmentosa due to a mutation in the NR2E3 gene.
    Terray A; Slembrouck A; Nanteau C; Chondroyer C; Zeitz C; Sahel JA; Audo I; Reichman S; Goureau O
    Stem Cell Res; 2017 Oct; 24():1-4. PubMed ID: 29034877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem cells derived from a patient with autosomal dominant familial neurohypophyseal diabetes insipidus caused by a variant in the AVP gene.
    Toustrup LB; Zhou Y; Kvistgaard H; Gregersen N; Rittig S; Aagaard L; Corydon TJ; Luo Y; Christensen JH
    Stem Cell Res; 2017 Mar; 19():37-42. PubMed ID: 28413003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of human iPSCs from urine derived cells of patient with a novel heterozygous PAI-1 mutation.
    Afzal MZ; Gartz M; Klyachko EA; Khan SS; Shah SJ; Gupta S; Shapiro AD; Vaughan DE; Strande JL
    Stem Cell Res; 2017 Jan; 18():41-44. PubMed ID: 28395801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of an iPSC line from a patient with tyrosine hydroxylase (TH) deficiency: TH-1 iPSC.
    Jung-Klawitter S; Blau N; Sebe A; Ebersold J; Göhring G; Opladen T
    Stem Cell Res; 2016 Nov; 17(3):580-583. PubMed ID: 27934587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of human iPSCs from urine derived cells of a patient with a novel homozygous PAI-1 mutation.
    Afzal MZ; Gartz M; Klyachko EA; Khan SS; Shah SJ; Gupta S; Shapiro AD; Vaughan DE; Strande JL
    Stem Cell Res; 2016 Nov; 17(3):657-660. PubMed ID: 27934602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoblast-derived integration-free iPS cell line from a female 67-year-old Alzheimer's disease patient with TREM2 (R47H) missense mutation.
    Schröter F; Sleegers K; Cuyvers E; Bohndorf M; Wruck W; Van Broeckhoven C; Adjaye J
    Stem Cell Res; 2016 Nov; 17(3):553-555. PubMed ID: 27789408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of human induced pluripotent stem cell (iPSC) line from an unaffected female carrier of Mucopolysaccharidosis type II (MPS II) disorder.
    Varga E; Nemes C; Kovács E; Bock I; Varga N; Fehér A; Dinnyés A; Kobolák J
    Stem Cell Res; 2016 Nov; 17(3):514-516. PubMed ID: 27789401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a human induced pluripotent stem cell (iPSC) line from a 64year old male patient with multiple schwannoma.
    Zhang S; Lv Z; Hu Y; Liu L; Gong W; Li Q; Wu H
    Stem Cell Res; 2017 Mar; 19():49-51. PubMed ID: 28413006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Episomal plasmid-based generation of an iPSC line from an 83-year-old individual carrying the APOE4/4 genotype: i10984.
    Zulfiqar S; Fritz B; Nieweg K
    Stem Cell Res; 2016 Nov; 17(3):523-525. PubMed ID: 27789402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient.
    Zhang S; Liu L; Hu Y; Lv Z; Li Q; Gong W; Sha H; Wu H
    Stem Cell Res; 2017 Mar; 19():43-45. PubMed ID: 28413004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.